These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1121 related items for PubMed ID: 16256775

  • 1. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO, Starling RC, Khaykin Y, McCarthy PM, Young JB, Hail M, Albert NM, Smedira N, Chung MK.
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [Abstract] [Full Text] [Related]

  • 2. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH, Yee R, Jung W.
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [Abstract] [Full Text] [Related]

  • 3. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 4. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Mar; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P.
    Circulation; 2009 Jul 21; 120(3):194-200. PubMed ID: 19581496
    [Abstract] [Full Text] [Related]

  • 6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.
    Bigger JT.
    N Engl J Med; 1997 Nov 27; 337(22):1569-75. PubMed ID: 9371853
    [Abstract] [Full Text] [Related]

  • 8. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
    Ypenburg C, van Erven L, Bleeker GB, Bax JJ, Bootsma M, Wijffels MC, van der Wall EE, Schalij MJ.
    J Am Coll Cardiol; 2006 Aug 01; 48(3):464-70. PubMed ID: 16875970
    [Abstract] [Full Text] [Related]

  • 9. Gender differences in device therapy for malignant ventricular arrhythmias.
    Horton HL, Marinchak RA, Rials SJ, Kowey PR.
    Arch Intern Med; 1995 Nov 27; 155(21):2342-5. PubMed ID: 7487260
    [Abstract] [Full Text] [Related]

  • 10. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C, Zhu AX, Vanheel L, Sakaguchi RN, Lurie KG, Lu F, Benditt DG.
    Europace; 2007 May 27; 9(5):270-4. PubMed ID: 17371804
    [Abstract] [Full Text] [Related]

  • 11. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
    J Am Coll Cardiol; 2011 Sep 27; 58(14):1485-96. PubMed ID: 21939834
    [Abstract] [Full Text] [Related]

  • 12. [Electrical storm in patients with implantable cardioverter-defibrillator].
    Bárzaga FJ, Clavijo PC, Sánchez MD, Hevia JC, Molina RZ, Pérez MA, Leza JB, Rodríguez YF, Balea FD.
    Arch Cardiol Mex; 2008 Sep 27; 78(1):68-78. PubMed ID: 18581715
    [Abstract] [Full Text] [Related]

  • 13. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G, Rea RF, Hammill SC, Hayes DL, Brady PA.
    Heart; 2008 Feb 27; 94(2):186-90. PubMed ID: 17761506
    [Abstract] [Full Text] [Related]

  • 14. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.
    Circulation; 2008 Apr 15; 117(15):1918-26. PubMed ID: 18391108
    [Abstract] [Full Text] [Related]

  • 15. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A, Trinquart L, Marijon E, Lavergne T, Waintraub X, Lepillier A, Chatellier G, Le Heuzey JY, EVADEF investigators.
    Am Heart J; 2009 Aug 15; 158(2):230-237.e1. PubMed ID: 19619699
    [Abstract] [Full Text] [Related]

  • 16. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.
    Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L.
    Ann Thorac Surg; 2008 Apr 15; 85(4):1278-81. PubMed ID: 18355509
    [Abstract] [Full Text] [Related]

  • 17. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A.
    Pacing Clin Electrophysiol; 2007 Mar 15; 30(3):390-4. PubMed ID: 17367359
    [Abstract] [Full Text] [Related]

  • 18. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

  • 19. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung E, Menon S, Nallamothu BK, Chan PS.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):50-8. PubMed ID: 17207722
    [Abstract] [Full Text] [Related]

  • 20. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C.
    Arch Gen Psychiatry; 2008 Nov 02; 65(11):1324-30. PubMed ID: 18981344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.